MORINO, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 466
EU - Europa 332
AS - Asia 73
SA - Sud America 14
AF - Africa 5
OC - Oceania 1
Totale 891
Nazione #
US - Stati Uniti d'America 447
IT - Italia 152
FR - Francia 49
DE - Germania 31
NL - Olanda 29
CA - Canada 17
IN - India 17
JP - Giappone 17
RU - Federazione Russa 16
CZ - Repubblica Ceca 14
UA - Ucraina 11
HK - Hong Kong 8
CL - Cile 7
CN - Cina 7
GB - Regno Unito 7
PH - Filippine 7
ES - Italia 5
AE - Emirati Arabi Uniti 4
BR - Brasile 4
IR - Iran 4
ZA - Sudafrica 4
FI - Finlandia 3
IE - Irlanda 3
PT - Portogallo 3
AR - Argentina 2
IL - Israele 2
MX - Messico 2
OM - Oman 2
SG - Singapore 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
IQ - Iraq 1
LT - Lituania 1
LU - Lussemburgo 1
PE - Perù 1
RO - Romania 1
SE - Svezia 1
TH - Thailandia 1
TR - Turchia 1
UG - Uganda 1
Totale 891
Città #
Rome 94
Santa Cruz 54
Fairfield 38
Ashburn 34
Seattle 28
Buffalo 25
Winston-Salem 17
Houston 16
Moscow 12
Cambridge 10
Woodbridge 10
Milan 9
Delft 8
Des Moines 8
Paris 8
Essen 7
San Diego 7
Anguillara 6
Bengaluru 6
Las Vegas 6
Messina 6
Quezon City 6
Wilmington 6
Ann Arbor 5
Boardman 5
Dallas 5
Los Angeles 5
New York 5
San Jose 5
Chicago 4
Council Bluffs 4
Krefeld 4
Lille 4
Reutlingen 4
Tokyo 4
Boca Raton 3
Brooklyn 3
Central 3
Dublin 3
Frankfurt am Main 3
Henderson 3
Jacksonville 3
Provo 3
Shanghai 3
Amsterdam 2
Apex 2
Baltimore 2
Bologna 2
Bristol 2
Delhi 2
Federal 2
Gainesville 2
Helsinki 2
London 2
Moncalieri 2
Montreal 2
Muizenberg 2
Munich 2
Naples 2
Ottawa 2
Palo Alto 2
Portland 2
Pownal 2
Salem 2
San Nicolás de los Garza 2
Santa Coloma de Gramenet 2
Singapore 2
Sumiyoshi 2
São Paulo 2
Taranto 2
Toronto 2
Toulouse 2
Antalya 1
Apeldoorn 1
Ashland 1
Aurora 1
Baghdad 1
Bangkok 1
Basking Ridge 1
Berlin 1
Birmingham 1
Bitritto 1
Boston 1
Bremen 1
Cardano al Campo 1
Cascina 1
Catania 1
Catanzaro 1
Changsha 1
Chapel Hill 1
Chernivtsi 1
Chester 1
Clearwater 1
Coronel 1
Cuenca 1
Dearborn 1
Dubai 1
Durham 1
Edmonton 1
Falls Church 1
Totale 586
Nome #
Novel ACTA1 mutation causes late-presenting nemaline myopathy with unusual dark cores, file e3835328-db2e-15e8-e053-a505fe0a3de9 228
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials, file e383532d-bf5c-15e8-e053-a505fe0a3de9 121
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis, file e3835324-5f3d-15e8-e053-a505fe0a3de9 100
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension, file e383532b-28f8-15e8-e053-a505fe0a3de9 83
Efficacy and safety of IVIG in CIDP. Combined data of the PRIMA and PATH studies, file e3835324-3028-15e8-e053-a505fe0a3de9 82
Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy. Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study, file e3835324-8bdc-15e8-e053-a505fe0a3de9 71
Consistent improvement with eculizumab across muscle groups in myasthenia gravis, file e3835327-2898-15e8-e053-a505fe0a3de9 52
Muscle MRI in immune-mediated necrotizing myopathy (IMNM). implications for clinical management and treatment strategies, file 836b331c-9194-4439-bab0-b43b4c08108a 40
Comparison of quantitative muscle ultrasound and whole-body muscle MRI in facioscapulohumeral muscular dystrophy type 1 patients, file 102b75da-3b37-4431-b920-e82cee251903 22
Eculizumab improves fatigue in refractory generalized myasthenia gravis, file e3835324-7bb1-15e8-e053-a505fe0a3de9 22
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN). a phase 3, randomised, double-blind, placebo-controlled, multicentre study, file e383531b-1d5c-15e8-e053-a505fe0a3de9 17
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN). a phase 3, randomised, double-blind, placebo-controlled, multicentre study, file e383531b-1d5b-15e8-e053-a505fe0a3de9 14
Nerve high-resolution ultrasonography in peripheral nerve injuries associated with supracondylar humeral fractures in children, file e3835323-5279-15e8-e053-a505fe0a3de9 10
Quantitative sensory testing and skin biopsy findings in late‐onset ATTRv pre‐symptomatic carriers: relationships with predicted time of disease onset (PADO), file 7fdc64e6-00bf-4581-943c-753eb5adc427 6
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH). a randomised, double-blind, placebo-controlled, phase 3 trial, file e383531b-1d57-15e8-e053-a505fe0a3de9 6
Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis (Quality of Life Research, (2019), 28, 8, (2247-2254), 10.1007/s11136-019-02148-2), file 7477e5af-de07-41d1-bbe0-39e0ee63d43f 5
A 34-year longitudinal study on long-term cardiac outcomes in DM1 patients with normal ECG at baseline at an Italian clinical centre, file e383531b-5580-15e8-e053-a505fe0a3de9 5
Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis. A subgroup analysis of the REGAIN open-label extension study, file a101748c-bffb-496b-bcc8-14fc5e215c27 4
Distal upper limb involvement in myasthenia-myositis association, file 0f000f58-7f4b-47cc-bcd3-b1e2225642c5 3
Multifocal motor neuropathy following treatment with adalimumab for ulcerative colitis, file e383531b-564f-15e8-e053-a505fe0a3de9 3
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis. 2-year extension of the MGTX randomised trial, file e3835324-8bd8-15e8-e053-a505fe0a3de9 3
Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of Myasthenia-Myositis association from a large cohort of patients, file e3835325-8be8-15e8-e053-a505fe0a3de9 3
Gender effect on cardiac involvement in myotonic dystrophy type 1, file e3835328-db30-15e8-e053-a505fe0a3de9 3
Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors, file f077556c-8ed6-4a76-8f3b-4993408a3bc5 3
Intravenous versus subcutaneous immunoglobulin – authors' reply, file e383531d-9812-15e8-e053-a505fe0a3de9 2
Plasma-exchange responsive delayed pseudochoreoathetosis in a patient with anti-Hu neuronopathy, file e383531e-1e62-15e8-e053-a505fe0a3de9 2
Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy, file e3835327-7a4f-15e8-e053-a505fe0a3de9 2
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT). a multicentre, randomised, placebo-controlled, phase 3 trial, file e383532c-5660-15e8-e053-a505fe0a3de9 2
Prominent mitochondrial pathology in a case of refractory dermatomyositis: coincidence or concause?, file 3521afd9-d68b-4c5c-b651-5d0ed82e68a0 1
null, file a29d5398-ae0c-485c-98a0-5a5773c11940 1
Widening the phenotypical spectrum of EGR2-related CMT: unusual phenotype for R409W mutation, file e383531e-2a23-15e8-e053-a505fe0a3de9 1
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis, file e3835324-3ef2-15e8-e053-a505fe0a3de9 1
Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up, file e383532a-faca-15e8-e053-a505fe0a3de9 1
High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP, file e383532d-e4a1-15e8-e053-a505fe0a3de9 1
Totale 920
Categoria #
all - tutte 2.256
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.256


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 2 0 0
2019/202084 0 0 0 2 6 2 13 20 21 5 9 6
2020/202185 3 6 6 3 9 4 5 8 11 12 15 3
2021/2022257 10 5 10 23 22 15 21 18 18 17 67 31
2022/2023266 7 14 53 47 18 24 11 29 15 16 16 16
2023/2024193 14 8 15 22 31 22 23 33 13 12 0 0
Totale 920